Catalyst Wire Dossier Catalyst Wire Dossier

SLV339

· Solvay Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SLV339, covering 2009-08-06 to 2009-08-06. Get the full timeline:

Most recent: Clinical Trial Update: Dose-ranging Study to Evaluate Efficacy of SLV339 in Pancreatic Exocrine Insufficiency Due to Chronic Pancreatitis [Phase 2]

See pricing